PanTheryx is a vertically-integrated medical nutrition company dedicated to improving global health and quality of life through innovative life science. Utilizing its broad-based proprietary technology platform, PanTheryx is focused on the research, development and commercialization of medical nutrition products targeting the gastrointestinal microbiome. The company distributes its products internationally through licensing relationships with major pharmaceutical partners with access to broad distribution networks. The company’s lead product, DiaResQ targets acute pediatric infectious diarrhea, a leading cause of death worldwide among children under the age of five. DiaResQ has been shown to be both safe and efficacious in clinical trial settings and was selected by the Innovation Countdown 2030 initiative (led by PATH, the Bill & Melinda Gates Foundation, USAID and others) as one of the 30 leading healthcare innovations with great promise to transform global health by 2030.
Location: United States, Arizona, Phoenix
Total raised: $103M
Investors 2
| Date | Name | Website |
| - | Pegasus Ca... | pcalp.com |
| - | Perceptive... | perceptive... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 27.06.2019 | - | $50M | Perceptive... |
| 30.03.2016 | - | $53M | - |
Mentions in press and media 12
| Date | Title | Description |
| 29.09.2025 | Lindsey Carnett to Speak at PDMI Conference, PDMI-West, in San Diego | Performance marketing agency, Marketing Maven, announced today that its CEO and President, Lindsey Carnett, will be the moderator at PDMI West for a panel on October 7. The panel will address “Leveraging the Power of Influencers.” The Perfo... |
| 28.11.2023 | Business | Boulder biotech firm PanTheryx raises $52M | BOULDER — PanTheryx Inc., a Boulder-based life-sciences company that makes health products from bovine colostrum, a type of milk produced by a mammal mother immediately after giving birth, recently raised more than $52 million from investor... |
| 11.06.2021 | Cow Colostrum Sales Surging Amid Increasing Application in Dietary Supplements and Cosmetics Industries: Future Market Insights Study USA - English USA - English USA - English | |
| 07.04.2021 | Got (first) milk? Bovine colostrum firm targets food & beverage as immunity trend gathers pace | The stuff lactating mammals produce just after giving birth, colostrum is packed with immunoglobulins and other nutrients that help support a newborn’s immune system and seed a healthy gut microbiome in the first few days of life. While ‘bo... |
| 27.06.2019 | PanTheryx Receives $50M | BOULDER, CO, PanTheryx announced today that it has completed $50 million in new financing. >> Click here for more funding data on PanTheryx >> To export PanTheryx funding data to PDF and Excel, click here PanTheryx, a bio... |
| 27.06.2019 | PanTheryx Raises $50 Million From Perceptive Advisors | BOULDER, Colo.--(BUSINESS WIRE)--PanTheryx, a biotechnology company focused on addressing serious GI related health conditions, announced today that it has completed $50 million in new financing with Perceptive Advisors. Proceeds from the f... |
| 27.06.2019 | PanTheryx Raises $50M in Financing | PanTheryx, a Boulder, CO-based biotechnology company focused on addressing serious GI related health conditions, completed a $50m financing round. Perceptive Advisors made the investment, which brings the total financing raised by PanTheryx... |
| 27.06.2019 | PanTheryx Announces $50 Million Financing, Accelerates Development of its Novel Biologics and Medical Foods Candidates | - |
| 26.06.2019 | Boulder biotech company PanTheryx gets $50 million | Boulder biotechnology company PanTheryx is getting $50 million from Perceptive Advisors to develop treatments for a variety of gut-related medical conditions and to promote its medical foods, the company announced today. PanTheryx leverages... |
| 30.03.2016 | PanTheryx Raises $53M in Financing | PanTheryx, Inc., a Boulder, Colorado-based medical nutrition company, raised $53m in financing. Pegasus Capital Advisors made the investment. The company intends to use the funds to support the global commercial launch of its infectious dia... |
Show more